Capsid Tropism Screening Platforms Market Outlook Featuring Demand Trends And Future Growth Potential
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Capsid Tropism Screening Platforms Market During 2026–2030?
In recent years, the capsid tropism screening platforms market size has experienced swift expansion. It is projected to increase from $0.74 billion in 2025 to $0.85 billion in 2026, at a compound annual growth rate (CAGR) of 14.2%. The historical growth can be ascribed to escalating investment in gene therapy research, the rising demand for viral vector optimization, the adoption of flow cytometry and sequencing technologies, a heightened focus on personalized medicine, and the expansion of pharmaceutical and biotech R&D infrastructure.
The market size for capsid tropism screening platforms is anticipated to experience swift expansion over the next few years. It is projected to achieve a value of $1.45 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.4%. This growth during the forecast period is attributable to the increasing application of AI-driven capsid tropism analysis, the expanding use of high-content imaging and microfluidics, a surging demand for single-cell sequencing and advanced screening platforms, the enlargement of contract research organizations (CROs), and the greater integration of multiplex assay and digital PCR technologies. Significant trends for the forecast period include the increasing adoption of high-throughput screening platforms, a rising demand for next-generation sequencing solutions, the growing integration of flow cytometry technologies, the expansion of assay kits and reagent product lines, and an elevated focus on applications in gene therapy and vaccine development.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Factors Are Influencing The Growth Of The Capsid Tropism Screening Platforms Market?
The escalating demand for targeted gene therapies is projected to propel the expansion of the capsid tropism screening platforms market throughout the forecast period. These specialized gene therapies focus on delivering therapeutic genetic material to specific cells or tissues to correct, modify, or replace defective genes associated with disease. The increasing need for such therapies is fueled by several factors, including the rising prevalence of genetic and rare diseases, advancements in vector engineering technologies, and augmented investment in precision medicine approaches aimed at enhancing treatment efficacy while minimizing off-target effects. Capsid tropism screening platforms are pivotal in gene therapy development, allowing for the systematic evaluation and selection of viral vectors with optimal tissue and cell specificity. For instance, in January 2024, the American Society of Gene & Cell Therapy, a US-based organization for gene and cell therapy, reported that the number of gene therapies in Phase III clinical trials increased by 10% in the fourth quarter of 2023, marking the first quarterly rise since the third quarter of 2022. Therefore, the growing demand for targeted gene therapies is a key driver for the growth of the capsid tropism screening platforms market.
How Is The Capsid Tropism Screening Platforms Market Broken Down By Segment Categories?
The capsid tropism screening platforms market covered in this report is segmented –
1) By Technology: High-Throughput Screening, Next-Generation Sequencing, Flow Cytometry, Other Technologies
2) By Product Type: Assay Kits, Reagents, Instruments, Software, Services
3) By Application: Gene Therapy Development, Vaccine Development, Drug Discovery, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users
Subsegments:
1) By High-Throughput Screening: Cell-Based Screening, Biochemical Screening, High-Content Screening, Automated Screening, Label-Free Screening
2) By Next-Generation Sequencing: Short-Read Sequencing, Long-Read Sequencing, Targeted Sequencing, Whole-Genome Sequencing, Single-Cell Sequencing
3) By Flow Cytometry: Conventional Flow Cytometry, Spectral Flow Cytometry, Imaging Flow Cytometry, Cell Sorting, Mass Cytometry
4) By Other Technologies: Microfluidics-Based Screening, High-Content Imaging, Mass Spectrometry, Polymerase Chain Reaction And Digital Polymerase Chain Reaction, Immunoassay-Based Platforms
What Trends Are Transforming The Capsid Tropism Screening Platforms Market?
Leading companies in the capsid tropism screening platforms market are entering into strategic partnerships to develop innovative high-throughput and barcoded adeno-associated virus screening solutions. These strategic alliances drive the growth of the capsid tropism screening platforms market by fostering collaborative advancement of sophisticated adeno-associated virus screening technologies, expanding product ranges, and accelerating both gene therapy research and its commercialization. For instance, in August 2025, PackGene Biotech Inc., a US-based biotechnology company, finalized a strategic licensing agreement with the Children’s Medical Research Institute (CMRI), an Australia-based independent organization, with the aim of commercializing barcoded high-throughput adeno-associated virus capsid screening kits. These kits enable researchers to rapidly evaluate numerous adeno-associated virus capsid variants simultaneously through the use of a barcode system and next-generation sequencing. The collaboration’s goal is to expedite gene therapy development by simplifying capsid selection and enhancing access to advanced screening instruments.
Which Players Are Present In The Capsid Tropism Screening Platforms Market Space?
Major companies operating in the capsid tropism screening platforms market are Sarepta Therapeutics Inc., Voyager Therapeutics Inc., Bluebird Bio Inc., Sangamo Therapeutics Inc., REGENXBIO Inc., MeiraGTx Holdings plc, Dyno Therapeutics Inc., 4D Molecular Therapeutics Inc., Asklepios BioPharmaceutical Inc., PackGene Biotech Inc., Creative Biolabs Inc., VectorBuilder Inc., uniQure N.V., Homology Medicines Inc., Capsida Biotherapeutics Inc., LogicBio Therapeutics Inc., Capsigen Inc., GeneMedi Inc., Spark Therapeutics Inc., Creative Biogene Inc.
Get The Full Capsid Tropism Screening Platforms Market Report:
https://www.thebusinessresearchcompany.com/report/capsid-tropism-screening-platforms-market-report
Which Region Is The Leading Market For The Capsid Tropism Screening Platforms Market?
North America was the largest region in the capsid tropism screening platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the capsid tropism screening platforms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Capsid Tropism Screening Platforms Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Capsid Tropism Screening Platforms Market 2026, By The Business Research Company
adeno-associated virus (avv) vectors in gene therapy market report 2026
gastric cancer therapy market report 2026
https://www.thebusinessresearchcompany.com/report/gastric-cancer-therapy-global-market-report
over the counter (otc) drugs market report 2026
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
